Screening of inhibitors of human telomerase reverse transcriptase in a cultured malignant melanoma cell line [16]

British Journal of Dermatology

Volumn 150, Issue 2, 2004, Pages 388-390

  Hu, S ^a,b   Liao, S K ^b   Pang, J H S ^b   Chen, M C ^a,b   Chen, C H ^a,b   Hong, H S ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; BISINDOLYLMALEIMIDE; BUFFER; CISPLATIN; COMPLEMENTARY DNA; DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; FLUOROURACIL; HERBIMYCIN A; MESSENGER RNA; METHOTREXATE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PACLITAXEL; QUERCETIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TELOMERASE REVERSE TRANSCRIPTASE; VINBLASTINE;

CANCER CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LABORATORY TEST; LETTER; MELANOMA CELL; MOLONEY LEUKEMIA ONCOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TEMPERATURE; TIME;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; HUMANS; MELANOMA; RNA, NEOPLASM; TELOMERASE;

EID: 1542611365     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05802.x     Document Type: Letter

References (10)

1. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989; 337: 331-7.
2. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-15.
3. Nakamura TM, Morin GB, Chapman KB et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-9.
4. Ulaner GA, Hu JF, Vu TH et al. Telomerase activity in human development is regulated by hTERT transcription and by alternating splicing of hTERT transcripts. Cancer Res 1998; 58: 4168-72.
5. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996; 8: 66-71.
6. Villa R, Porta CD, Folini M et al. Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma. J Invest Dermatol 2001; 116: 867-73.
7. Dhaene K, Vancoillie G, Lambert J et al. Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures. Br J Cancer 2000; 82: 1051-7.
8. Melamed DE, Føgh J, Andreeff M. Characterization of cultured human tumor cell lines by flow cytometry DNA stemline. Anal Quant Cytol 1981; 3: 67-72.
9. Chen Q, Wei W. Effects and mechanisms of melatonin on inflammatory and immune responses of adjuvant arthritis rat. Int Immunopharmacol 2002; 2: 1443-9.
10. Hidaka H, Inagaki M, Kawamoto S et al. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984; 23: 5036-41.